161 related articles for article (PubMed ID: 18922443)
21. Thromboelastometry to guide recombinant activated factor VII therapy for postoperative refractory intracranial bleeding.
Hirasaki Y; Suematsu Y; Yasuda T; Tajima K
Anesth Analg; 2010 Jan; 110(1):261-2. PubMed ID: 20023190
[No Abstract] [Full Text] [Related]
22. Pharmacologic therapy for postoperative bleeding in children after cardiac surgery: when will the bleeding stop?
Yan Q; Chang AC
Pediatr Crit Care Med; 2004 May; 5(3):297-8. PubMed ID: 15167716
[No Abstract] [Full Text] [Related]
23. Invited commentary.
Welsby IJ; Ortel TL
Ann Thorac Surg; 2007 Jul; 84(1):168-9. PubMed ID: 17588405
[No Abstract] [Full Text] [Related]
24. [Recombinant activated factor VII for perioperative bleeding].
López R; Aeschlimann N; Carvajal C; Lema G
Rev Med Chil; 2009 Jun; 137(6):837-43. PubMed ID: 19746288
[TBL] [Abstract][Full Text] [Related]
25. Invited commentary.
Shander A; Javidroozi M
Ann Thorac Surg; 2008 Mar; 85(3):844. PubMed ID: 18291153
[No Abstract] [Full Text] [Related]
26. [Our experience with recombinant activated factor VII (NovoSeven) in the high risk cardiosurgical patients with bleeding complication].
Miskolczi S; Vaszily M; Papp C; Péterffy A
Magy Seb; 2008; 61 Suppl():45-7. PubMed ID: 18504237
[TBL] [Abstract][Full Text] [Related]
27. Off-label use of recombinant factor VIIA concentrates after cardiac surgery.
Despotis G; Avidan M; Lublin DM
Ann Thorac Surg; 2005 Jul; 80(1):3-5. PubMed ID: 15975330
[No Abstract] [Full Text] [Related]
28. [Use of activated recombinant factor VII in patients with brain injury or undergoing brain surgery].
Ingelmo Ingelmo I; Rama-Maceiras P; Fàbregas Julià N; Hernández Palazón J
Rev Esp Anestesiol Reanim; 2009; 56(6):339-42. PubMed ID: 19725340
[No Abstract] [Full Text] [Related]
29. Was systemic venous thrombosis really due to the administration of recombinant factor VIIa? or was it possibly a manifestation of Lemierre syndrome?
Saeed G; Ganster G; Friedel N
Tex Heart Inst J; 2008; 35(3):373-4; author reply 374-6. PubMed ID: 18941643
[No Abstract] [Full Text] [Related]
30. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.
Agarwal HS; Bennett JE; Churchwell KB; Christian KG; Drinkwater DC; He Y; Taylor MB
Ann Thorac Surg; 2007 Jul; 84(1):161-8. PubMed ID: 17588404
[TBL] [Abstract][Full Text] [Related]
31. Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding.
Economou M; Teli A; Tzantzaroudi A; Tsatra I; Zavitsanakis A; Athanassiou-Metaxa M
Haemophilia; 2008 Mar; 14(2):390-1. PubMed ID: 18194305
[No Abstract] [Full Text] [Related]
32. Safety and efficiency of recombinant activated factor VII in postcardiotomy massive hemorrhage.
Lamarche Y; Demers P; Poirier NC; Robitaille D; Cartier R
Can J Cardiol; 2007 Aug; 23(10):809-13. PubMed ID: 17703260
[TBL] [Abstract][Full Text] [Related]
33. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.
Daniloś J; Goral A; Paluszkiewicz P; Przesmycki K; Kotarski J
Obstet Gynecol; 2003 Jun; 101(6):1172-3. PubMed ID: 12798520
[TBL] [Abstract][Full Text] [Related]
34. Relative risks of recombinant factor VII.
McMullan DM
Pediatr Crit Care Med; 2009 Sep; 10(5):604-5. PubMed ID: 19741450
[No Abstract] [Full Text] [Related]
35. [Application of recombinant activated factor VII in gynecological intervention (case report)].
Nacheva A; Gateva Zh; Atanasova V
Akush Ginekol (Sofiia); 2004; 43 Suppl 4():3-5. PubMed ID: 15673003
[No Abstract] [Full Text] [Related]
36. Recombinant activated factor VII following pediatric cardiac surgery.
Kylasam S; Mos K; Fijtin S; Webster B; Chard R; Egan J
J Intensive Care Med; 2009; 24(2):116-21. PubMed ID: 19188273
[TBL] [Abstract][Full Text] [Related]
37. Use of recombinant activated factor VII in children.
Hammer GB; Williams GD
Paediatr Anaesth; 2007 Dec; 17(12):1123-5. PubMed ID: 17986029
[No Abstract] [Full Text] [Related]
38. A Propensity-Score Matched Analysis on Outcomes Using Recombinant Activated Factor VII in Pediatric Cardiac Surgery.
Li Y; Zhao W; Luo Q; Wu X; Ding J; Yan F
J Cardiothorac Vasc Anesth; 2019 May; 33(5):1269-1275. PubMed ID: 30795967
[TBL] [Abstract][Full Text] [Related]
39. [Risk assessment of thrombotic events after the use of activated factor VII].
Martínez López MC; Alcaraz Romero AJ; Martínez López AB; Fernández-Llamazares CM; Ramos Navarro C
An Pediatr (Barc); 2013 Sep; 79(3):177-81. PubMed ID: 23265723
[TBL] [Abstract][Full Text] [Related]
40. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
